Use of 99m Tc-sestamibi SPECT/CT when conventional imaging studies are negative for localizing suspected recurrence in differentiated thyroid cancer: a method and a lesson for clinical management

Conclusions99mTc-sestamibi may have a role in thyroid cancer localization when physical exam, neck ultrasound, radioiodine scan, chest/abdomen CT, and18F-FDG PET/CT does not identify the source of elevated Tg levels in DTC.
Source: Endocrine - Category: Endocrinology Source Type: research